Christel Thea Jorgensen

Title: Christel Thea Jorgensen: Innovator in Alpha-Amylase Variants

Introduction

Christel Thea Jorgensen is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of alpha-amylase variants. With a total of 11 patents to her name, Jorgensen has established herself as a leading figure in her area of expertise.

Latest Patents

Among her latest innovations are variants of a parent Termamyl-like alpha-amylase. These variants exhibit altered properties, specifically a reduced capability of cleaving a substrate close to the branching point. Additionally, they demonstrate improved substrate specificity and/or enhanced specific activity compared to the parent alpha-amylase. This work has the potential to impact various applications in the industry.

Career Highlights

Jorgensen is currently employed at Novozymes A/S, a company renowned for its focus on biotechnology and enzyme production. Her work at Novozymes has allowed her to explore and develop innovative solutions that contribute to the advancement of enzyme technology.

Collaborations

Throughout her career, Jorgensen has collaborated with notable colleagues, including Allan Svendsen and Carsten Schau Andersen. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Christel Thea Jorgensen is a trailblazer in the field of alpha-amylase variants, with a strong portfolio of patents and a commitment to innovation. Her contributions continue to shape the future of biotechnology and enzyme applications.